CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Ayrton Drugs Manufacturing Company Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Ayrton Drugs Manufacturing Company Ltd
NR CMB Flats, Mokose Road, Tesano
Phone: +233 02245090p:+233 02245090 ACCRA, Ghana Ticker: AYRTNAYRTN
Business Summary
Ayrton Drug Manufacturing Company Limited manufactures, imports and supplies pharmaceutical products in West Africa. The Company offers various products, including Antitussives, such as Samalin Adult, Samalin Junior and Samalin Non-Drowsy Junior; Apetite stimulants and vitamin, such as Ayrton Multivitamin Syrup, and Heptamin Syrup and Capsules; Anti-Hypertensives, such as Adco-Atenolol; Blood and Iron Tonics, such as Virol Blood Tonic and Haemoglobin Syrup; Dermatological, such as Clobet Triple Action and Clofen Gel; Anti-Allergy, such as Allergex and Allergex Elixir; Antacid, such as Res Q Tablets and Syrups; Anti-Diarrohoea, such as Adco-Loperamide tablets; Analgesics/Antipyretics/Non-steriodal, such as Baby Paralex, Panacin and Paracetamol Tablet; Anti-bacterial, such as Amoxycillin and Cotrimoxazole Tablets, and Antiprotozoal, such as Metronidazole Suspension.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20196/30/2017Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman RichardAdu-Poku
Managing Director, Executive Director Daniel A.Kissi 12/1/2012 12/1/2012
Secretary OpokuAmponsah
Non-Executive Director NikAmarteifio 73 10/4/2017 10/4/2017
Non-Executive Director John Y.Opare Asamoah 10/4/2017 10/4/2017

Business Names
Business Name
AYRTN
Ayrton Drugs Manufacturing Company Ltd
Ayrton Drugs Manufacturing Company Ltd.

General Information
Outstanding Shares: 215,000,000 (As of 9/30/2019)
Shareholders: 3,976
Stock Exchange: GHA
Fax Number: +233 02241804


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 5, 2024